Davin Dum

11PUBLICATIONS
41CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 28, 2026
TROP2 Is Uniformly Expressed in Primary Prostate Cancer but Frequently Reduced in Recurrent Disease.

|Jul 28, 2026
Expression of Thymidylate Synthase in Cancer: A Tissue Microarray Study Involving 17,371 Cancers from 136 Tumor Entities.

|Nov 04, 2025
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer.

Neele Heckmann, Henning Plage, Ronald Simon

|Aug 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype.

Viktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis

|Jul 29, 2025
Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 Tumors.

Maria Christina Tsourlakis, Simon Kind, Sebastian Dwertmann Rico

|Apr 02, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.

Seyma Büyücek, Florian Viehweger, Viktor Reiswich

Pageof 2

Frequent Collaborators

11 joint publications

Maximilian Lennartz

11 joint publications

Ronald Simon

8 joint publications

Claudia Hube-Magg

8 joint publications

Till S Clauditz